ARTICLE | Clinical News
PBT-1 clioquinol: Phase II
December 22, 2003 8:00 AM UTC
In an Australian Phase II trial in 36 patients, PBT-1 improved cognitive performance and reduced serum amyloid levels compared to placebo. Patients with higher ADAS-cog scores showed an average deteri...